323 related articles for article (PubMed ID: 25661320)
1. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
2. Mucus permeating thiomer nanoparticles.
Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
[TBL] [Abstract][Full Text] [Related]
3. Protease-functionalized mucus penetrating microparticles: In-vivo evidence for their potential.
Mahmood A; Laffleur F; Leonaviciute G; Bernkop-Schnürch A
Int J Pharm; 2017 Oct; 532(1):177-184. PubMed ID: 28864390
[TBL] [Abstract][Full Text] [Related]
4. The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.
Wilcox MD; Van Rooij LK; Chater PI; Pereira de Sousa I; Pearson JP
Eur J Pharm Biopharm; 2015 Oct; 96():484-7. PubMed ID: 25758122
[TBL] [Abstract][Full Text] [Related]
5. Development and in vivo evaluation of papain-functionalized nanoparticles.
Müller C; Perera G; König V; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2014 May; 87(1):125-31. PubMed ID: 24373995
[TBL] [Abstract][Full Text] [Related]
6. Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier.
Menzel C; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2018 Jan; 124():164-174. PubMed ID: 29079537
[TBL] [Abstract][Full Text] [Related]
7. Mucus permeating self-emulsifying drug delivery systems (SEDDS): About the impact of mucolytic enzymes.
Efiana NA; Phan TNQ; Wicaksono AJ; Bernkop-Schnürch A
Colloids Surf B Biointerfaces; 2018 Jan; 161():228-235. PubMed ID: 29080507
[TBL] [Abstract][Full Text] [Related]
8. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles.
Pereira de Sousa I; Steiner C; Schmutzler M; Wilcox MD; Veldhuis GJ; Pearson JP; Huck CW; Salvenmoser W; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):273-9. PubMed ID: 25576256
[TBL] [Abstract][Full Text] [Related]
9. Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate.
Efiana NA; Dizdarević A; Huck CW; Bernkop-Schnürch A
J Pharm Sci; 2019 Oct; 108(10):3329-3339. PubMed ID: 31136766
[TBL] [Abstract][Full Text] [Related]
10. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
[TBL] [Abstract][Full Text] [Related]
11. Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine.
Saleh A; Akkuş-Dağdeviren ZB; Haddadzadegan S; Wibel R; Bernkop-Schnürch A
Biomacromolecules; 2023 Jun; 24(6):2587-2595. PubMed ID: 37224061
[TBL] [Abstract][Full Text] [Related]
12. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
13. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
[TBL] [Abstract][Full Text] [Related]
14. Preactivated thiolated nanoparticles: A novel mucoadhesive dosage form.
Menzel C; Bonengel S; Pereira de Sousa I; Laffleur F; Prüfert F; Bernkop-Schnürch A
Int J Pharm; 2016 Jan; 497(1-2):123-8. PubMed ID: 26631639
[TBL] [Abstract][Full Text] [Related]
15. On the synthesis of mucus permeating nanocarriers.
Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus.
Laffleur F; Hintzen F; Shahnaz G; Rahmat D; Leithner K; Bernkop-Schnürch A
Nanomedicine (Lond); 2014 Mar; 9(3):387-96. PubMed ID: 23611618
[TBL] [Abstract][Full Text] [Related]
17. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
18. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
19. Nano-carrier systems: Strategies to overcome the mucus gel barrier.
Dünnhaupt S; Kammona O; Waldner C; Kiparissides C; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Oct; 96():447-53. PubMed ID: 25712487
[TBL] [Abstract][Full Text] [Related]
20. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
